St. Jude Medical Inc. (STJ)
-NYSE 47.00 
0.18(0.38%) May 17, 4:00PM EDT|After Hours
:
46.88 0.12 (0.25%) May 17, 5:16PM EDT
| Prev Close: | 46.82 |
|---|
| Open: | 46.84 |
|---|
| Bid: | 46.95 x 300 |
|---|
| Ask: | 47.24 x 200 |
|---|
| 1y Target Est: | 45.06 |
|---|
| Beta: | 1.3 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 46.70 - 47.16 |
|---|
| 52wk Range: | 30.25 - 47.16 |
|---|
| Volume: | 2,260,658 |
|---|
| Avg Vol (3m): | 2,458,570 |
|---|
| Market Cap: | 13.32B |
|---|
| P/E (ttm): | 18.91 |
|---|
| EPS (ttm): | 2.49 |
|---|
| Div & Yield: | 1.00 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why This Big Buyback Isn't a Long-Term Solutionat Motley Fool(Fri, May 17)
- CE Mark for STJ's ILUMIEN OPTISZacks(Fri, May 17)
- St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent PlacementBusiness Wire(Thu, May 16)
- Today's 3 Best Stocksat Motley Fool(Wed, May 15)
- Health Services Stocks On The Rise With Help From 5 Stocksat TheStreet(Wed, May 15)
- Study for STJ's Latest EnligHTNZacks(Wed, May 15)
- Good News for STJ's DurataZacks(Tue, May 14)
- St. Jude Medical announces first patient enrolled in EnligHTN III studyat theflyonthewall.com(Tue, May 14)
- St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN SystemBusiness Wire(Tue, May 14)
- St Jude Medical Inc. (STJ): Today's Featured Health Services Winnerat TheStreet(Mon, May 13)
- Novel Leadless Pacemaker Makes Debut At HRS 2013at Forbes(Mon, May 13)
- CE Mark for STJ's Ellipse & AssuraZacks(Mon, May 13)
- St Jude Medical Inc. Stock Buy Recommendation Reiterated (STJ)at TheStreet(Mon, May 13)
- ST JUDE MEDICAL INC FinancialsEDGAR Online Financials(Sat, May 11)
- Johnson & Johnson: At The Crossroads - Part IIat Seeking Alpha(Fri, May 10)
Key Statistics
| Forward P/E (1 yr): | 11.96 |
|---|
| P/S (ttm): | 2.44 |
|---|
| Ex-Dividend Date: | 26-Jun-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.70 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.94 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.32 |
|---|
Business Summary
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems.
View More